Cargando…
Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases
INTRODUCTION: Patients’ adherence to and persistence on treatment for inflammatory bowel disease (IBD) can vary, depending on type and distribution of disease and treatment modality. We aim to identify differences in adherence and persistence with treatments with different administration routes (int...
Autores principales: | Moran, Kellyn, Null, Kyle, Huang, Zhongwen, Lissoos, Trevor, Kane, Sunanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822974/ https://www.ncbi.nlm.nih.gov/pubmed/31385283 http://dx.doi.org/10.1007/s12325-019-01037-x |
Ejemplares similares
-
Response to “Comment on Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
por: Moran, Kellyn, et al.
Publicado: (2020) -
Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study
por: Chen, Grace, et al.
Publicado: (2020) -
Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases”
por: Woolcott, John, et al.
Publicado: (2020) -
Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
por: Khan, Nabeel, et al.
Publicado: (2017) -
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
por: Patel, Haridarshan, et al.
Publicado: (2017)